ArticleEClinicalMedicine2026

Safety and efficacy of intravenous onasemnogene abeparvovec gene therapy in patients with spinal muscular atrophy type 1: interim analysis from LT-001, a long-term follow-up study of patients from the START study.

Megan A Waldrop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.